rdf:type |
|
lifeskim:mentions |
umls-concept:C0021775,
umls-concept:C0030705,
umls-concept:C0034380,
umls-concept:C0055729,
umls-concept:C0080331,
umls-concept:C0085732,
umls-concept:C0184069,
umls-concept:C0282440,
umls-concept:C0678226,
umls-concept:C0920317,
umls-concept:C1280500,
umls-concept:C1704436,
umls-concept:C2712999
|
pubmed:issue |
12
|
pubmed:dateCreated |
2002-12-10
|
pubmed:abstractText |
To assess whether cilostazol, a phosphodiesterase III inhibitor, improves treadmill and community-based walking ability and health-related quality of life (HQL) in patients with intermittent claudication resulting from peripheral arterial disease (PAD).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0002-8614
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1939-46
|
pubmed:dateRevised |
2008-3-10
|
pubmed:meshHeading |
pubmed-meshheading:12473004-Aged,
pubmed-meshheading:12473004-Exercise Test,
pubmed-meshheading:12473004-Humans,
pubmed-meshheading:12473004-Intermittent Claudication,
pubmed-meshheading:12473004-Intracranial Arterial Diseases,
pubmed-meshheading:12473004-Male,
pubmed-meshheading:12473004-Multicenter Studies as Topic,
pubmed-meshheading:12473004-Peripheral Vascular Diseases,
pubmed-meshheading:12473004-Phosphodiesterase Inhibitors,
pubmed-meshheading:12473004-Polyhydroxyethyl Methacrylate,
pubmed-meshheading:12473004-Quality of Life,
pubmed-meshheading:12473004-Randomized Controlled Trials as Topic,
pubmed-meshheading:12473004-Tetrazoles,
pubmed-meshheading:12473004-Walking
|
pubmed:year |
2002
|
pubmed:articleTitle |
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
|
pubmed:affiliation |
Department of Medicine, Division of Internal Medicine and Cardiology, The University of Colorado Health Sciences Center, Denver 80262, USA. judy.regensteiner@uchsc.edu
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|